A compound of Formula (I) ** Formula ** in which ** Formula ** X represents N or CH； Y represents N or CR6； R1 represents (C1-4) alkyl； cycloalkyl (C3-6)； (C1-4) alkoxy； cycloalkoxy (C3-6)； fluoroalkyl (C1-3)； fluoroalkoxy (C1-3)； halogen； cyano； (C1-2) alkoxy-(C2-3) alkoxy； (C1-3) alkyl which is mono-substituted with -NR7R8； (C2-3) alkoxy which is mono-substituted with -NR7R8； heterocyclyl, wherein the heterocyclyl is a 4 to 6 membered monocyclic saturated ring containing one or two heteroatoms independently selected from nitrogen and oxygen and wherein said heterocyclyl is unsubstituted or mono-substituted with C1-2 alkyl )； or heterocyclyloxy, wherein the heterocyclyl is a 4- to 6-membered monocyclic saturated ring containing an oxygen atom； R2 represents hydrogen, (C1-4) alkoxy or fluorine； R3 represents hydrogen or methyl； R4 represents (C1-4) alkyl, or (C1-2) alkyl that is mono-substituted with -NR7R8； R5 represents (C1-4) alkyl； R6 represents hydrogen, (C1-4) alkyl or fluorine； or R1 and R6 form, together with the carbon atoms to which they are attached, a 5- or 6-membered heterocyclic ring, in which the remainder necessary to complete said heterocyclic ring is selected from -OCH2CH2- *, -OCH2O- * , -OCH2CH2CH2- * and -OCH2CH2O- *, in which the asterisks indicate the bond that is linked to the carbon atom carrying R6； R7 represents (C1-2) alkyl； and R8 represents (C1-2) alkyl； or a pharmaceutically acceptable salt thereof.Un compuesto de Fórmula (I) **Fórmula** en la que**Fórmula** X representa N o CH； Y representa N o CR6； R1 representa alquilo (C1-4)； cicloalquilo (C3-6)； alcoxi (C1-4)； cicloalcoxi (C3-6)； fluoroalquilo (C1-3)； fluoroalcoxi (C1-3)； halógeno； ciano； alcoxi (C1-2) - alcoxi (C2-3)； alquilo (C1-3) que está mono-sustituido con -NR7R8； alcoxi (C2-3) que está mono-sustituido con -NR7R8； heterociclilo, en el que el heterociclilo es un anillo saturado mono- cíclico de 4 a 6 miembros que contiene uno o dos heteroátomos independientemente seleccionado
